FDA.reportPublic FDA data

ABILIFY

Product NDC
59148-009
11-digit product format
591480009
Labeler code
59148
Product ID
59148-009_1b189d15-798d-4bed-a93d-a543ed7abd81
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ARIPIPRAZOLE
Dosage form
TABLET
Route
ORAL
Labeler
Otsuka America Pharmaceutical, Inc.
Application
NDA021436
Marketing category
NDA
Marketing start
2002-11-15
Substance
ARIPIPRAZOLE
Active strength
15 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
ABILIFY
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ARIPIPRAZOLE15 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii82VFR53I78
Rxcui349490, 349545, 349547, 349553, 352307, 352308, 352309, 352310, 402131, 404602, 602964, 615172

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
915afeb5-0b22-42c0-86ea-77abf1c5fe15Product name120250307
51c1e9bf-32c5-4a7b-b010-f93a90af7b6eProduct name120231010
34645f32-2ac4-41bf-9c61-8107e4764a26Product name120181210
f8ff9e17-cd6c-4547-98c3-f5db0d1fc25dProduct name120180110
14eaf619-f285-4cd0-9f39-d9dd8f3d9c02Product name120170824
8223ef47-de85-24dd-a9c7-5a041d2634a2Product name920170223

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
59148-009-132021-08-04C16284748780-1c7ccaba7-1f9b-fd44-e053-dadaa90aa01bThese highlights do not include all the information needed to use ABILIFY safely and effectively. See full prescribing information for ABILIFY. ABILIFY ® (aripiprazole) Tablets, for oral use Initial U.S. Approval: 2002
59148-009-352021-08-04C16284748780-1c7ccaba7-1f9b-fd44-e053-dadaa90aa01bThese highlights do not include all the information needed to use ABILIFY safely and effectively. See full prescribing information for ABILIFY. ABILIFY ® (aripiprazole) Tablets, for oral use Initial U.S. Approval: 2002
59148-009-952021-08-04C16284748780-1c7ccaba7-1f9b-fd44-e053-dadaa90aa01bThese highlights do not include all the information needed to use ABILIFY safely and effectively. See full prescribing information for ABILIFY. ABILIFY ® (aripiprazole) Tablets, for oral use Initial U.S. Approval: 2002
59148-009-132021-07-23C16284748780-1c7ccaba7-1f9b-fd44-e053-dadaa90aa01bThese highlights do not include all the information needed to use ABILIFY safely and effectively. See full prescribing information for ABILIFY. ABILIFY ® (aripiprazole) Tablets, for oral use Initial U.S. Approval: 2002
59148-009-352021-07-23C16284748780-1c7ccaba7-1f9b-fd44-e053-dadaa90aa01bThese highlights do not include all the information needed to use ABILIFY safely and effectively. See full prescribing information for ABILIFY. ABILIFY ® (aripiprazole) Tablets, for oral use Initial U.S. Approval: 2002
59148-009-952021-07-23C16284748780-1c7ccaba7-1f9b-fd44-e053-dadaa90aa01bThese highlights do not include all the information needed to use ABILIFY safely and effectively. See full prescribing information for ABILIFY. ABILIFY ® (aripiprazole) Tablets, for oral use Initial U.S. Approval: 2002

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59148-009-13ABILIFY30 in 1 BOTTLE, PLASTICTABLET3073
59148-009-35ABILIFY100 in 1 BLISTER PACKTABLET10073
59148-009-95ABILIFY7 in 1 BLISTER PACKTABLET773

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
59148-009-13EA - Each59148-00980014c8a-7f01-496e-9a91-9b6b1a67e14412012-07-24
59148-009-35EA - Each59148-009ca630bb1-7d1a-42dd-a9aa-b79d772a2adc12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ARIPIPRAZOLEACTIVE INGREDIENT82VFR53I78ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
ARIPIPRAZOLEACTIVE MOIETY82VFR53I78ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
ACESULFAME POTASSIUMINACTIVE INGREDIENT23OV73Q5G9ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
ALUMINUM OXIDEINACTIVE INGREDIENTLMI26O6933ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
CALCIUM SILICATEINACTIVE INGREDIENTS4255P4G5MABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
CROSPOVIDONEINACTIVE INGREDIENT68401960MKABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G675ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRTABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
FRUCTOSEINACTIVE INGREDIENT6YSS42VSEVABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
GLYCERININACTIVE INGREDIENTPDC6A3C0OXABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
HYDROXYPROPYL CELLULOSE (TYPE H)INACTIVE INGREDIENTRFW2ET671PABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
LACTIC ACID, DL-INACTIVE INGREDIENT3B8D35Y7S4ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
PHENYLALANINEINACTIVE INGREDIENT47E5O17Y3RABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OHABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32IABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
SUCROSEINACTIVE INGREDIENTC151H8M554ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
SULFOBUTYLETHER .BETA.-CYCLODEXTRININACTIVE INGREDIENT2PP9364507ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
TARTARIC ACIDINACTIVE INGREDIENTW4888I119HABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
WATERINACTIVE INGREDIENT059QF0KO0RABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
XYLITOLINACTIVE INGREDIENTVCQ006KQ1EABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
ARIPIPRAZOLEACTIVE INGREDIENT82VFR53I78ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]2
ARIPIPRAZOLEACTIVE INGREDIENT82VFR53I78ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]2
ARIPIPRAZOLEACTIVE MOIETY82VFR53I78ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]2
ARIPIPRAZOLEACTIVE MOIETY82VFR53I78ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]2
ALUMINUM OXIDEINACTIVE INGREDIENTLMI26O6933ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]2
ALUMINUM OXIDEINACTIVE INGREDIENTLMI26O6933ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]2
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]2
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]2
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G675ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]2
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G675ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]2
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRTABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]2
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRTABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]2
HYDROXYPROPYL CELLULOSE (TYPE H)INACTIVE INGREDIENTRFW2ET671PABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]2
HYDROXYPROPYL CELLULOSE (TYPE H)INACTIVE INGREDIENTRFW2ET671PABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]2
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]2
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]2
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]2
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
59148-009ABILIFY (ARIPIPRAZOLE) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.]73Current NDC, Legacy NDC, 3 package rows20250201_c040bd1d-45b7-49f2-93ea-aed7220b30ac.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
352307ABILIFY 10 MG Oral TabletPSNc040bd1d-45b7-49f2-93ea-aed7220b30ac73
352308ABILIFY 15 MG Oral TabletPSNc040bd1d-45b7-49f2-93ea-aed7220b30ac73
615172ABILIFY 2 MG Oral TabletPSNc040bd1d-45b7-49f2-93ea-aed7220b30ac73
352309ABILIFY 20 MG Oral TabletPSNc040bd1d-45b7-49f2-93ea-aed7220b30ac73
352310ABILIFY 30 MG Oral TabletPSNc040bd1d-45b7-49f2-93ea-aed7220b30ac73
404602ABILIFY 5 MG Oral TabletPSNc040bd1d-45b7-49f2-93ea-aed7220b30ac73
349545ARIPiprazole 10 MG Oral TabletPSNc040bd1d-45b7-49f2-93ea-aed7220b30ac73
349490ARIPiprazole 15 MG Oral TabletPSNc040bd1d-45b7-49f2-93ea-aed7220b30ac73
602964ARIPiprazole 2 MG Oral TabletPSNc040bd1d-45b7-49f2-93ea-aed7220b30ac73
349553ARIPiprazole 20 MG Oral TabletPSNc040bd1d-45b7-49f2-93ea-aed7220b30ac73
349547ARIPiprazole 30 MG Oral TabletPSNc040bd1d-45b7-49f2-93ea-aed7220b30ac73
402131ARIPiprazole 5 MG Oral TabletPSNc040bd1d-45b7-49f2-93ea-aed7220b30ac73
352307aripiprazole 10 MG Oral Tablet [Abilify]SBDc040bd1d-45b7-49f2-93ea-aed7220b30ac73
352308aripiprazole 15 MG Oral Tablet [Abilify]SBDc040bd1d-45b7-49f2-93ea-aed7220b30ac73
615172aripiprazole 2 MG Oral Tablet [Abilify]SBDc040bd1d-45b7-49f2-93ea-aed7220b30ac73
352309aripiprazole 20 MG Oral Tablet [Abilify]SBDc040bd1d-45b7-49f2-93ea-aed7220b30ac73
352310aripiprazole 30 MG Oral Tablet [Abilify]SBDc040bd1d-45b7-49f2-93ea-aed7220b30ac73
404602aripiprazole 5 MG Oral Tablet [Abilify]SBDc040bd1d-45b7-49f2-93ea-aed7220b30ac73
349545aripiprazole 10 MG Oral TabletSCDc040bd1d-45b7-49f2-93ea-aed7220b30ac73
349490aripiprazole 15 MG Oral TabletSCDc040bd1d-45b7-49f2-93ea-aed7220b30ac73
602964aripiprazole 2 MG Oral TabletSCDc040bd1d-45b7-49f2-93ea-aed7220b30ac73
349553aripiprazole 20 MG Oral TabletSCDc040bd1d-45b7-49f2-93ea-aed7220b30ac73
349547aripiprazole 30 MG Oral TabletSCDc040bd1d-45b7-49f2-93ea-aed7220b30ac73
402131aripiprazole 5 MG Oral TabletSCDc040bd1d-45b7-49f2-93ea-aed7220b30ac73
352307Abilify 10 MG Oral TabletSYc040bd1d-45b7-49f2-93ea-aed7220b30ac73
352308Abilify 15 MG Oral TabletSYc040bd1d-45b7-49f2-93ea-aed7220b30ac73
615172Abilify 2 MG Oral TabletSYc040bd1d-45b7-49f2-93ea-aed7220b30ac73
352309Abilify 20 MG Oral TabletSYc040bd1d-45b7-49f2-93ea-aed7220b30ac73
352310Abilify 30 MG Oral TabletSYc040bd1d-45b7-49f2-93ea-aed7220b30ac73
404602Abilify 5 MG Oral TabletSYc040bd1d-45b7-49f2-93ea-aed7220b30ac73
352308ABILIFY 15 MG Oral TabletPSNf9648990-0627-4c66-aae1-d3eef398b5b43
349490ARIPiprazole 15 MG Oral TabletPSNf9648990-0627-4c66-aae1-d3eef398b5b43
352308aripiprazole 15 MG Oral Tablet [Abilify]SBDf9648990-0627-4c66-aae1-d3eef398b5b43
349490aripiprazole 15 MG Oral TabletSCDf9648990-0627-4c66-aae1-d3eef398b5b43
352308Abilify 15 MG Oral TabletSYf9648990-0627-4c66-aae1-d3eef398b5b43
352308ABILIFY 15 MG Oral TabletPSNd0640208-44e9-4052-a56f-9a4cd9a5aaab2
349490ARIPiprazole 15 MG Oral TabletPSNd0640208-44e9-4052-a56f-9a4cd9a5aaab2
352308aripiprazole 15 MG Oral Tablet [Abilify]SBDd0640208-44e9-4052-a56f-9a4cd9a5aaab2
349490aripiprazole 15 MG Oral TabletSCDd0640208-44e9-4052-a56f-9a4cd9a5aaab2
352308Abilify 15 MG Oral TabletSYd0640208-44e9-4052-a56f-9a4cd9a5aaab2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
59148-009-135914800091330 TABLET in 1 BOTTLE, PLASTIC (59148-009-13) 30 tablet2002-11-150000-00-00NoNoCurrent
59148-009-3559148000935100 TABLET in 1 BLISTER PACK (59148-009-35) 100 tablet2002-11-150000-00-00NoNoCurrent
59148-009-95591480009957 TABLET in 1 BLISTER PACK (59148-009-95) 7 tablet2002-11-150000-00-00NoNoCurrent